NEW YORK (GenomeWeb) – 908 Devices today announced that it has closed an $11.6 million Series C round of financing, providing the company with funds to expand commercialization efforts around its M908 miniature mass spectrometry device, as well as develop the product for new applications in the oil and gas, environmental, and life science markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.